BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bayer L, Eggermann E, Serafin M, Saint-Mleux B, Machard D, Jones B, Mühlethaler M. Orexins (hypocretins) directly excite tuberomammillary neurons. Eur J Neurosci 2001;14:1571-5. [PMID: 11722619 DOI: 10.1046/j.0953-816x.2001.01777.x] [Cited by in Crossref: 134] [Cited by in F6Publishing: 126] [Article Influence: 6.7] [Reference Citation Analysis]
Number Citing Articles
1 Levine AS, Jewett DC, Kotz CM, Olszewski PK. Behavioral plasticity: Role of neuropeptides in shaping feeding responses. Appetite 2022;:106031. [PMID: 35395362 DOI: 10.1016/j.appet.2022.106031] [Reference Citation Analysis]
2 Anaclet C, Parmentier R, Ouk K, Guidon G, Buda C, Sastre JP, Akaoka H, Sergeeva OA, Yanagisawa M, Ohtsu H, Franco P, Haas HL, Lin JS. Orexin/hypocretin and histamine: distinct roles in the control of wakefulness demonstrated using knock-out mouse models. J Neurosci 2009;29:14423-38. [PMID: 19923277 DOI: 10.1523/JNEUROSCI.2604-09.2009] [Cited by in Crossref: 131] [Cited by in F6Publishing: 86] [Article Influence: 10.1] [Reference Citation Analysis]
3 De la Herrán-Arita AK, García-García F. Current and emerging options for the drug treatment of narcolepsy. Drugs 2013;73:1771-81. [PMID: 24122734 DOI: 10.1007/s40265-013-0127-y] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 3.1] [Reference Citation Analysis]
4 Tyree SM, Borniger JC, de Lecea L. Hypocretin as a Hub for Arousal and Motivation. Front Neurol 2018;9:413. [PMID: 29928253 DOI: 10.3389/fneur.2018.00413] [Cited by in Crossref: 37] [Cited by in F6Publishing: 28] [Article Influence: 9.3] [Reference Citation Analysis]
5 Cason AM, Smith RJ, Tahsili-Fahadan P, Moorman DE, Sartor GC, Aston-Jones G. Role of orexin/hypocretin in reward-seeking and addiction: implications for obesity. Physiol Behav 2010;100:419-28. [PMID: 20338186 DOI: 10.1016/j.physbeh.2010.03.009] [Cited by in Crossref: 155] [Cited by in F6Publishing: 150] [Article Influence: 12.9] [Reference Citation Analysis]
6 Kim J, Nakajima K, Oomura Y, Wayner MJ, Sasaki K. Electrophysiological effects of orexins/hypocretins on pedunculopontine tegmental neurons in rats: an in vitro study. Peptides 2009;30:191-209. [PMID: 18977258 DOI: 10.1016/j.peptides.2008.09.023] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 2.0] [Reference Citation Analysis]
7 Carvajal F, Alcaraz-iborra M, Lerma-cabrera JM, Valor LM, de la Fuente L, Sanchez-amate MDC, Cubero I. Orexin receptor 1 signaling contributes to ethanol binge-like drinking: Pharmacological and molecular evidence. Behavioural Brain Research 2015;287:230-7. [DOI: 10.1016/j.bbr.2015.03.046] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
8 Kotz CM. Integration of feeding and spontaneous physical activity: role for orexin. Physiol Behav 2006;88:294-301. [PMID: 16787655 DOI: 10.1016/j.physbeh.2006.05.031] [Cited by in Crossref: 67] [Cited by in F6Publishing: 64] [Article Influence: 4.2] [Reference Citation Analysis]
9 Zhou W, Cheung K, Kyu S, Wang L, Guan Z, Kurien PA, Bickler PE, Jan LY. Activation of orexin system facilitates anesthesia emergence and pain control. Proc Natl Acad Sci U S A 2018;115:E10740-7. [PMID: 30348769 DOI: 10.1073/pnas.1808622115] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 6.0] [Reference Citation Analysis]
10 Govindaiah G, Cox CL. Modulation of thalamic neuron excitability by orexins. Neuropharmacology 2006;51:414-25. [PMID: 16713607 DOI: 10.1016/j.neuropharm.2006.03.030] [Cited by in Crossref: 44] [Cited by in F6Publishing: 39] [Article Influence: 2.8] [Reference Citation Analysis]
11 Morales A, Bonnet C, Bourgoin N, Touvier T, Nadam J, Laglaine A, Navarro F, Moulin C, Georges B, Pequignot JM, Bezin L. Unexpected expression of orexin-B in basal conditions and increased levels in the adult rat hippocampus during pilocarpine-induced epileptogenesis. Brain Res 2006;1109:164-75. [PMID: 16904080 DOI: 10.1016/j.brainres.2006.06.075] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.2] [Reference Citation Analysis]
12 Motawaj M, Burban A, Davenas E, Gbahou F, Faucard R, Morisset S, Arrang J. Le système histaminergique : une cible pour de nouveaux traitements des deficits cognitifs. Therapies 2010;65:415-22. [DOI: 10.2515/therapie/2010058] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
13 Aracri P, Banfi D, Pasini ME, Amadeo A, Becchetti A. Hypocretin (orexin) regulates glutamate input to fast-spiking interneurons in layer V of the Fr2 region of the murine prefrontal cortex. Cereb Cortex 2015;25:1330-47. [PMID: 24297328 DOI: 10.1093/cercor/bht326] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 3.2] [Reference Citation Analysis]
14 Tarnal V, Vlisides PE, Mashour GA. The Neurobiology of Anesthetic Emergence. J Neurosurg Anesthesiol. 2016;28:250-255. [PMID: 26274626 DOI: 10.1097/ana.0000000000000212] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 3.2] [Reference Citation Analysis]
15 Rosin DL, Weston MC, Sevigny CP, Stornetta RL, Guyenet PG. Hypothalamic orexin (hypocretin) neurons express vesicular glutamate transporters VGLUT1 or VGLUT2. J Comp Neurol 2003;465:593-603. [PMID: 12975818 DOI: 10.1002/cne.10860] [Cited by in Crossref: 166] [Cited by in F6Publishing: 170] [Article Influence: 8.7] [Reference Citation Analysis]
16 Panula P, Nuutinen S. The histaminergic network in the brain: basic organization and role in disease. Nat Rev Neurosci 2013;14:472-87. [DOI: 10.1038/nrn3526] [Cited by in Crossref: 179] [Cited by in F6Publishing: 168] [Article Influence: 19.9] [Reference Citation Analysis]
17 Hoang QV, Zhao P, Nakajima S, Nakajima Y. Orexin (hypocretin) effects on constitutively active inward rectifier K+ channels in cultured nucleus basalis neurons. J Neurophysiol 2004;92:3183-91. [PMID: 15269229 DOI: 10.1152/jn.01222.2003] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 1.7] [Reference Citation Analysis]
18 Perez-Leighton CE, Butterick-Peterson TA, Billington CJ, Kotz CM. Role of orexin receptors in obesity: from cellular to behavioral evidence. Int J Obes (Lond) 2013;37:167-74. [PMID: 22391883 DOI: 10.1038/ijo.2012.30] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
19 Yamuy J, Fung SJ, Xi M, Chase MH. Hypocretinergic control of spinal cord motoneurons. J Neurosci 2004;24:5336-45. [PMID: 15190106 DOI: 10.1523/JNEUROSCI.4812-03.2004] [Cited by in Crossref: 58] [Cited by in F6Publishing: 34] [Article Influence: 3.2] [Reference Citation Analysis]
20 Parks GS, Warrier DR, Dittrich L, Schwartz MD, Palmerston JB, Neylan TC, Morairty SR, Kilduff TS. The Dual Hypocretin Receptor Antagonist Almorexant is Permissive for Activation of Wake-Promoting Systems. Neuropsychopharmacology 2016;41:1144-55. [PMID: 26289145 DOI: 10.1038/npp.2015.256] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
21 James MH, Campbell EJ, Dayas CV. Role of the Orexin/Hypocretin System in Stress-Related Psychiatric Disorders. Curr Top Behav Neurosci 2017;33:197-219. [PMID: 28083790 DOI: 10.1007/7854_2016_56] [Cited by in Crossref: 55] [Cited by in F6Publishing: 55] [Article Influence: 11.0] [Reference Citation Analysis]
22 Lin L, Wisor J, Shiba T, Taheri S, Yanai K, Wurts S, Lin X, Vitaterna M, Takahashi J, Lovenberg T, Koehl M, Uhl G, Nishino S, Mignot E. Measurement of hypocretin/orexin content in the mouse brain using an enzyme immunoassay: the effect of circadian time, age and genetic background. Peptides 2002;23:2203-11. [DOI: 10.1016/s0196-9781(02)00251-6] [Cited by in Crossref: 41] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
23 Berridge CW, España RA, Vittoz NM. Hypocretin/orexin in arousal and stress. Brain Res 2010;1314:91-102. [PMID: 19748490 DOI: 10.1016/j.brainres.2009.09.019] [Cited by in Crossref: 115] [Cited by in F6Publishing: 115] [Article Influence: 8.8] [Reference Citation Analysis]
24 Sepúlveda PO, Tapia LF, Monsalves S. Neural inertia and differences between loss of and recovery from consciousness during total intravenous anaesthesia: a narrative review. Anaesthesia 2019;74:801-9. [DOI: 10.1111/anae.14609] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
25 Graebner AK, Iyer M, Carter ME. Understanding how discrete populations of hypothalamic neurons orchestrate complicated behavioral states. Front Syst Neurosci 2015;9:111. [PMID: 26300745 DOI: 10.3389/fnsys.2015.00111] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.9] [Reference Citation Analysis]
26 Lin J, Dauvilliers Y, Arnulf I, Bastuji H, Anaclet C, Parmentier R, Kocher L, Yanagisawa M, Lehert P, Ligneau X, Perrin D, Robert P, Roux M, Lecomte J, Schwartz J. An inverse agonist of the histamine H3 receptor improves wakefulness in narcolepsy: Studies in orexin−/− mice and patients. Neurobiology of Disease 2008;30:74-83. [DOI: 10.1016/j.nbd.2007.12.003] [Cited by in Crossref: 188] [Cited by in F6Publishing: 175] [Article Influence: 13.4] [Reference Citation Analysis]
27 Burdakov D, Alexopoulos H. Metabolic state signalling through central hypocretin/orexin neurons. J Cell Mol Med 2005;9:795-803. [PMID: 16364191 DOI: 10.1111/j.1582-4934.2005.tb00380.x] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 2.3] [Reference Citation Analysis]
28 Iqbal J, Henry B, Pompolo S, Rao A, Clarke I. Long-term alteration in bodyweight and food restriction does not affect the gene expression of either preproorexin or prodynorphin in the sheep. Neuroscience 2003;118:217-26. [DOI: 10.1016/s0306-4522(02)00815-1] [Cited by in Crossref: 23] [Cited by in F6Publishing: 2] [Article Influence: 1.2] [Reference Citation Analysis]
29 Chen A, Singh C, Oikonomou G, Prober DA. Genetic Analysis of Histamine Signaling in Larval Zebrafish Sleep. eNeuro 2017;4:ENEURO. [PMID: 28275716 DOI: 10.1523/ENEURO.0286-16.2017] [Cited by in Crossref: 17] [Cited by in F6Publishing: 8] [Article Influence: 3.4] [Reference Citation Analysis]
30 Nevárez N, de Lecea L. Hypocretin and the Regulation of Sleep-Wake Transitions. Handbook of Sleep Research. Elsevier; 2019. pp. 89-99. [DOI: 10.1016/b978-0-12-813743-7.00006-2] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
31 Riahi E, Arezoomandan R, Fatahi Z, Haghparast A. The electrical activity of hippocampal pyramidal neuron is subjected to descending control by the brain orexin/hypocretin system. Neurobiology of Learning and Memory 2015;119:93-101. [DOI: 10.1016/j.nlm.2015.02.001] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
32 Matsuki T, Sakurai T. Orexins and Orexin Receptors: From Molecules to Integrative Physiology. In: Civelli O, Zhou Q, editors. Orphan G Protein-Coupled Receptors and Novel Neuropeptides. Berlin: Springer Berlin Heidelberg; 2008. pp. 27-55. [DOI: 10.1007/400_2007_047] [Cited by in Crossref: 51] [Cited by in F6Publishing: 45] [Reference Citation Analysis]
33 Hasegawa E, Yanagisawa M, Sakurai T, Mieda M. Orexin neurons suppress narcolepsy via 2 distinct efferent pathways. J Clin Invest 2014;124:604-16. [PMID: 24382351 DOI: 10.1172/JCI71017] [Cited by in Crossref: 96] [Cited by in F6Publishing: 49] [Article Influence: 12.0] [Reference Citation Analysis]
34 Morairty SR, Wisor J, Silveira K, Sinko W, Kilduff TS. The wake-promoting effects of hypocretin-1 are attenuated in old rats. Neurobiol Aging 2011;32:1514-27. [PMID: 19781813 DOI: 10.1016/j.neurobiolaging.2009.07.017] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
35 Samuels ER, Szabadi E. Functional neuroanatomy of the noradrenergic locus coeruleus: its roles in the regulation of arousal and autonomic function part I: principles of functional organisation. Curr Neuropharmacol 2008;6:235-53. [PMID: 19506723 DOI: 10.2174/157015908785777229] [Cited by in Crossref: 389] [Cited by in F6Publishing: 362] [Article Influence: 32.4] [Reference Citation Analysis]
36 Mileykovskiy BY, Kiyashchenko LI, Siegel JM. Behavioral correlates of activity in identified hypocretin/orexin neurons. Neuron 2005;46:787-98. [PMID: 15924864 DOI: 10.1016/j.neuron.2005.04.035] [Cited by in Crossref: 579] [Cited by in F6Publishing: 545] [Article Influence: 34.1] [Reference Citation Analysis]
37 Bonaventure P, Dugovic C, Shireman B, Preville C, Yun S, Lord B, Nepomuceno D, Wennerholm M, Lovenberg T, Carruthers N, Fitz SD, Shekhar A, Johnson PL. Evaluation of JNJ-54717793 a Novel Brain Penetrant Selective Orexin 1 Receptor Antagonist in Two Rat Models of Panic Attack Provocation. Front Pharmacol 2017;8:357. [PMID: 28649201 DOI: 10.3389/fphar.2017.00357] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 4.4] [Reference Citation Analysis]
38 Datta S, Maclean RR. Neurobiological mechanisms for the regulation of mammalian sleep-wake behavior: reinterpretation of historical evidence and inclusion of contemporary cellular and molecular evidence. Neurosci Biobehav Rev 2007;31:775-824. [PMID: 17445891 DOI: 10.1016/j.neubiorev.2007.02.004] [Cited by in Crossref: 194] [Cited by in F6Publishing: 166] [Article Influence: 12.9] [Reference Citation Analysis]
39 Satoh S, Matsumura H, Kanbayashi T, Yoshida Y, Urakami T, Nakajima T, Kimura N, Nishino S, Yoneda H. Expression pattern of FOS in orexin neurons during sleep induced by an adenosine A2A receptor agonist. Behavioural Brain Research 2006;170:277-86. [DOI: 10.1016/j.bbr.2006.03.010] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
40 Li J, Hu Z, de Lecea L. The hypocretins/orexins: integrators of multiple physiological functions. Br J Pharmacol 2014;171:332-50. [PMID: 24102345 DOI: 10.1111/bph.12415] [Cited by in Crossref: 153] [Cited by in F6Publishing: 141] [Article Influence: 19.1] [Reference Citation Analysis]
41 Johnson PL, Molosh A, Fitz SD, Truitt WA, Shekhar A. Orexin, stress, and anxiety/panic states. Prog Brain Res 2012;198:133-61. [PMID: 22813973 DOI: 10.1016/B978-0-444-59489-1.00009-4] [Cited by in Crossref: 125] [Cited by in F6Publishing: 69] [Article Influence: 12.5] [Reference Citation Analysis]
42 Luppi PH, Gervasoni D, Verret L, Goutagny R, Peyron C, Salvert D, Leger L, Fort P. Paradoxical (REM) sleep genesis: the switch from an aminergic-cholinergic to a GABAergic-glutamatergic hypothesis. J Physiol Paris 2006;100:271-83. [PMID: 17689057 DOI: 10.1016/j.jphysparis.2007.05.006] [Cited by in Crossref: 121] [Cited by in F6Publishing: 110] [Article Influence: 8.1] [Reference Citation Analysis]
43 de Lecea L, Sutcliffe JG, Fabre V. Hypocretins/orexins as integrators of physiological information: lessons from mutant animals. Neuropeptides 2002;36:85-95. [PMID: 12359500 DOI: 10.1054/npep.2002.0892] [Cited by in Crossref: 43] [Cited by in F6Publishing: 41] [Article Influence: 2.2] [Reference Citation Analysis]
44 Mieda M, Sakurai T. Overview of orexin/hypocretin system. Orexin/Hypocretin System. Elsevier; 2012. pp. 5-14. [DOI: 10.1016/b978-0-444-59489-1.00002-1] [Cited by in Crossref: 32] [Cited by in F6Publishing: 8] [Article Influence: 3.2] [Reference Citation Analysis]
45 De la Herrán-Arita AK, Guerra-Crespo M, Drucker-Colín R. Narcolepsy and orexins: an example of progress in sleep research. Front Neurol 2011;2:26. [PMID: 21541306 DOI: 10.3389/fneur.2011.00026] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
46 Haxhiu MA, Rust CF, Brooks C, Kc P. CNS determinants of sleep-related worsening of airway functions: implications for nocturnal asthma. Respir Physiol Neurobiol 2006;151:1-30. [PMID: 16198640 DOI: 10.1016/j.resp.2005.07.009] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
47 Xia J, Chen X, Cheng S, Hu Z. Mechanisms of orexin A-evoked changes of intracellular calcium in primary cultured cortical neurons: . NeuroReport 2005;16:783-6. [DOI: 10.1097/00001756-200505120-00025] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
48 Bayer L, Serafin M, Eggermann E, Saint-Mleux B, Machard D, Jones BE, Mühlethaler M. Exclusive postsynaptic action of hypocretin-orexin on sublayer 6b cortical neurons. J Neurosci 2004;24:6760-4. [PMID: 15282280 DOI: 10.1523/JNEUROSCI.1783-04.2004] [Cited by in Crossref: 110] [Cited by in F6Publishing: 46] [Article Influence: 6.5] [Reference Citation Analysis]
49 Umehara H, Mizuguchi H, Mizukawa N, Matsumoto M, Takeda N, Senba E, Fukui H. Deprivation of anticipated food under scheduled feeding induces c-Fos expression in the caudal part of the arcuate nucleus of hypothalamus through histamine H₁ receptors in rats: potential involvement of E3 subgroup of histaminergic neurons in tuberomammillary nucleus. Brain Res 2011;1387:61-70. [PMID: 21320473 DOI: 10.1016/j.brainres.2011.02.018] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
50 Mochizuki T, Arrigoni E, Marcus JN, Clark EL, Yamamoto M, Honer M, Borroni E, Lowell BB, Elmquist JK, Scammell TE. Orexin receptor 2 expression in the posterior hypothalamus rescues sleepiness in narcoleptic mice. Proc Natl Acad Sci U S A 2011;108:4471-6. [PMID: 21368172 DOI: 10.1073/pnas.1012456108] [Cited by in Crossref: 85] [Cited by in F6Publishing: 90] [Article Influence: 7.7] [Reference Citation Analysis]
51 Bayer L, Eggermann E, Saint-Mleux B, Machard D, Jones BE, Mühlethaler M, Serafin M. Selective action of orexin (hypocretin) on nonspecific thalamocortical projection neurons. J Neurosci 2002;22:7835-9. [PMID: 12223534 [PMID: 12223534 DOI: 10.1523/jneurosci.22-18-07835.2002] [Cited by in Crossref: 107] [Article Influence: 5.4] [Reference Citation Analysis]
52 Watson CJ, Baghdoyan HA, Lydic R. Neuropharmacology of Sleep and Wakefulness. Sleep Med Clin 2010;5:513-28. [PMID: 21278831 DOI: 10.1016/j.jsmc.2010.08.003] [Cited by in Crossref: 47] [Cited by in F6Publishing: 34] [Article Influence: 3.9] [Reference Citation Analysis]
53 Messina A, Monda M, Valenzano A, Messina G, Villano I, Moscatelli F, Cibelli G, Marsala G, Polito R, Ruberto M, Carotenuto M, Monda V, Viggiano A, Daniele A, Nigro E. Functional Changes Induced by Orexin A and Adiponectin on the Sympathetic/Parasympathetic Balance. Front Physiol 2018;9:259. [PMID: 29623046 DOI: 10.3389/fphys.2018.00259] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
54 Messina A, De Fusco C, Monda V, Esposito M, Moscatelli F, Valenzano A, Carotenuto M, Viggiano E, Chieffi S, De Luca V, Cibelli G, Monda M, Messina G. Role of the Orexin System on the Hypothalamus-Pituitary-Thyroid Axis. Front Neural Circuits 2016;10:66. [PMID: 27610076 DOI: 10.3389/fncir.2016.00066] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 3.3] [Reference Citation Analysis]
55 Rautkylä E, Puolakka M, Halonen L. Alerting effects of daytime light exposure – a proposed link between light exposure and brain mechanisms. Lighting Research & Technology 2012;44:238-52. [DOI: 10.1177/1477153511409294] [Cited by in Crossref: 26] [Cited by in F6Publishing: 7] [Article Influence: 2.4] [Reference Citation Analysis]
56 Kukkonen JP, Holmqvist T, Ammoun S, Åkerman KEO. Functions of the orexinergic/hypocretinergic system. American Journal of Physiology-Cell Physiology 2002;283:C1567-91. [DOI: 10.1152/ajpcell.00055.2002] [Cited by in Crossref: 200] [Cited by in F6Publishing: 188] [Article Influence: 10.0] [Reference Citation Analysis]
57 Luppi P, Fort P. Neurochemistry of sleep. Sleep Disorders. Elsevier; 2011. pp. 173-90. [DOI: 10.1016/b978-0-444-52006-7.00011-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
58 Nevárez N, de Lecea L. Recent advances in understanding the roles of hypocretin/orexin in arousal, affect, and motivation. F1000Res 2018;7:F1000 Faculty Rev-1421. [PMID: 30254737 DOI: 10.12688/f1000research.15097.1] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 5.8] [Reference Citation Analysis]
59 Brooks S, Black J. Novel therapies for narcolepsy. Expert Opinion on Investigational Drugs 2005;11:1821-7. [DOI: 10.1517/13543784.11.12.1821] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
60 Stahl SM. Selective histamine H1 antagonism: novel hypnotic and pharmacologic actions challenge classical notions of antihistamines. CNS Spectr 2008;13:1027-38. [PMID: 19179941 DOI: 10.1017/s1092852900017089] [Cited by in Crossref: 48] [Cited by in F6Publishing: 16] [Article Influence: 3.7] [Reference Citation Analysis]
61 Pekala D, Blasiak T, Raastad M, Lewandowski MH. The influence of orexins on the firing rate and pattern of rat intergeniculate leaflet neurons - electrophysiological and immunohistological studies: Influence of orexins on intergeniculate leaflet. European Journal of Neuroscience 2011;34:1406-18. [DOI: 10.1111/j.1460-9568.2011.07868.x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 2.7] [Reference Citation Analysis]
62 Overeem S, Reading P, Bassetti CL. Narcolepsy. Sleep Medicine Clinics 2012;7:263-81. [DOI: 10.1016/j.jsmc.2012.03.013] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
63 Muzur A. Toward an integrative theory of sleep and dreaming. Journal of Theoretical Biology 2005;233:103-18. [DOI: 10.1016/j.jtbi.2004.09.011] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
64 Yokoyama S, Kinoshita K, Muroi Y, Ishii T. The effects of bilateral lesions of the mesencephalic trigeminal sensory nucleus on nocturnal feeding and related behaviors in mice. Life Sci 2013;93:681-6. [PMID: 24063988 DOI: 10.1016/j.lfs.2013.09.015] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
65 Jones BE. Neurobiology of waking and sleeping. Handb Clin Neurol 2011;98:131-49. [PMID: 21056184 DOI: 10.1016/B978-0-444-52006-7.00009-5] [Cited by in Crossref: 41] [Cited by in F6Publishing: 18] [Article Influence: 3.7] [Reference Citation Analysis]
66 Ujita K, Kinoshita K, Muroi Y, Ishii T. The effects of unilateral lesion of the tuberomammillary nucleus E2 sub-region on nocturnal feeding and related behaviors in mice. Life Sci 2016;162:70-6. [PMID: 27515503 DOI: 10.1016/j.lfs.2016.08.004] [Reference Citation Analysis]
67 Abbas MG, Shoji H, Soya S, Hondo M, Miyakawa T, Sakurai T. Comprehensive Behavioral Analysis of Male Ox1r (-/-) Mice Showed Implication of Orexin Receptor-1 in Mood, Anxiety, and Social Behavior. Front Behav Neurosci 2015;9:324. [PMID: 26696848 DOI: 10.3389/fnbeh.2015.00324] [Cited by in Crossref: 40] [Cited by in F6Publishing: 32] [Article Influence: 5.7] [Reference Citation Analysis]
68 Xie X, Crowder TL, Yamanaka A, Morairty SR, Lewinter RD, Sakurai T, Kilduff TS. GABA(B) receptor-mediated modulation of hypocretin/orexin neurones in mouse hypothalamus. J Physiol 2006;574:399-414. [PMID: 16627567 DOI: 10.1113/jphysiol.2006.108266] [Cited by in Crossref: 61] [Cited by in F6Publishing: 63] [Article Influence: 3.8] [Reference Citation Analysis]
69 Watson CJ, Baghdoyan HA, Lydic R. Neuropharmacology of Sleep and Wakefulness: 2012 Update. Sleep Med Clin 2012;7:469-86. [PMID: 23162386 DOI: 10.1016/j.jsmc.2012.06.010] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
70 Torrealba F, Yanagisawa M, Saper CB. Colocalization of orexin a and glutamate immunoreactivity in axon terminals in the tuberomammillary nucleus in rats. Neuroscience 2003;119:1033-44. [PMID: 12831862 DOI: 10.1016/s0306-4522(03)00238-0] [Cited by in Crossref: 134] [Cited by in F6Publishing: 70] [Article Influence: 7.1] [Reference Citation Analysis]
71 Zhang LN, Yang C, Ouyang PR, Zhang ZC, Ran MZ, Tong L, Dong HL, Liu Y. Orexin-A facilitates emergence of the rat from isoflurane anesthesia via mediation of the basal forebrain. Neuropeptides. 2016;58:7-14. [PMID: 26919917 DOI: 10.1016/j.npep.2016.02.003] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 3.3] [Reference Citation Analysis]
72 Mobarakeh JI, Takahashi K, Sakurada S, Nishino S, Watanabe H, Kato M, Naghdi N, Yanai K. Enhanced antinociception by intracerebroventricularly administered orexin A in histamine H1 or H2 receptor gene knockout mice. Pain 2005;118:254-62. [DOI: 10.1016/j.pain.2005.08.024] [Cited by in Crossref: 33] [Cited by in F6Publishing: 25] [Article Influence: 1.9] [Reference Citation Analysis]
73 Kaplan GB, Lakis GA, Zhoba H. Sleep-Wake and Arousal Dysfunctions in Post-Traumatic Stress Disorder:Role of Orexin Systems. Brain Res Bull 2022:S0361-9230(22)00121-6. [PMID: 35618150 DOI: 10.1016/j.brainresbull.2022.05.006] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
74 Fujita A, Bonnavion P, Wilson MH, Mickelsen LE, Bloit J, de Lecea L, Jackson AC. Hypothalamic Tuberomammillary Nucleus Neurons: Electrophysiological Diversity and Essential Role in Arousal Stability. J Neurosci 2017;37:9574-92. [PMID: 28874450 DOI: 10.1523/JNEUROSCI.0580-17.2017] [Cited by in Crossref: 30] [Cited by in F6Publishing: 19] [Article Influence: 6.0] [Reference Citation Analysis]
75 Eggermann E, Bayer L, Serafin M, Saint-Mleux B, Bernheim L, Machard D, Jones BE, Mühlethaler M. The wake-promoting hypocretin-orexin neurons are in an intrinsic state of membrane depolarization. J Neurosci 2003;23:1557-62. [PMID: 12629156 [PMID: 12629156 DOI: 10.1523/jneurosci.23-05-01557.2003] [Cited by in Crossref: 113] [Article Influence: 5.9] [Reference Citation Analysis]
76 De Lecea L, Sutcliffe JG. The hypocretins and sleep: The hypocretins and sleep. FEBS Journal 2005;272:5675-88. [DOI: 10.1111/j.1742-4658.2005.04981.x] [Cited by in Crossref: 74] [Cited by in F6Publishing: 68] [Article Influence: 4.4] [Reference Citation Analysis]
77 De la Herrán-arita AK, Drucker-colín R. Models for narcolepsy with cataplexy drug discovery. Expert Opinion on Drug Discovery 2012;7:155-64. [DOI: 10.1517/17460441.2012.651454] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
78 Arzhang A, Elahdadi Salmani M, Lashkarbolouki T, Goudarzi I. Posterior hypothalamus glutamate infusion decreases pentylenetetrazol-induced seizures of male rats through hippocampal histamine increase. Pharmacol Biochem Behav 2017;158:7-13. [PMID: 28495313 DOI: 10.1016/j.pbb.2017.05.004] [Reference Citation Analysis]
79 de Lecea L, Huerta R. Hypocretin (orexin) regulation of sleep-to-wake transitions. Front Pharmacol. 2014;5:16. [PMID: 24575043 DOI: 10.3389/fphar.2014.00016] [Cited by in Crossref: 68] [Cited by in F6Publishing: 69] [Article Influence: 8.5] [Reference Citation Analysis]
80 Chen X, Chen L, Du Y. Orexin-A increases the firing activity of hippocampal CA1 neurons through orexin-1 receptors: Orexin-A in Hippocampal CA1 Neurons. Journal of Neuroscience Research 2017;95:1415-26. [DOI: 10.1002/jnr.23975] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 5.0] [Reference Citation Analysis]
81 Yamanaka A, Tabuchi S, Tsunematsu T, Fukazawa Y, Tominaga M. Orexin directly excites orexin neurons through orexin 2 receptor. J Neurosci. 2010;30:12642-12652. [PMID: 20861370 DOI: 10.1523/jneurosci.2120-10.2010] [Cited by in Crossref: 67] [Cited by in F6Publishing: 43] [Article Influence: 5.6] [Reference Citation Analysis]
82 Alam MA, Mallick BN. Glutamic acid stimulation of the perifornical-lateral hypothalamic area promotes arousal and inhibits non-REM/REM sleep. Neurosci Lett. 2008;439:281-286. [PMID: 18534750 DOI: 10.1016/j.neulet.2008.05.042] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 2.2] [Reference Citation Analysis]
83 Xia J, Chen X, Song C, Ye J, Yu Z, Hu Z. Postsynaptic excitation of prefrontal cortical pyramidal neurons by hypocretin-1/orexin A through the inhibition of potassium currents. J Neurosci Res 2005;82:729-36. [PMID: 16247802 DOI: 10.1002/jnr.20667] [Cited by in Crossref: 36] [Cited by in F6Publishing: 31] [Article Influence: 2.3] [Reference Citation Analysis]
84 Cascella M, Bimonte S, Muzio MR. Towards a better understanding of anesthesia emergence mechanisms: Research and clinical implications. World J Methodol 2018; 8(2): 9-16 [PMID: 30345225 DOI: 10.5662/wjm.v8.i2.9] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
85 Brown JA, Woodworth HL, Leinninger GM. To ingest or rest? Specialized roles of lateral hypothalamic area neurons in coordinating energy balance. Front Syst Neurosci 2015;9:9. [PMID: 25741247 DOI: 10.3389/fnsys.2015.00009] [Cited by in Crossref: 47] [Cited by in F6Publishing: 51] [Article Influence: 6.7] [Reference Citation Analysis]
86 Ishibashi M, Takano S, Yanagida H, Takatsuna M, Nakajima K, Oomura Y, Wayner MJ, Sasaki K. Effects of orexins/hypocretins on neuronal activity in the paraventricular nucleus of the thalamus in rats in vitro. Peptides 2005;26:471-81. [PMID: 15652654 DOI: 10.1016/j.peptides.2004.10.014] [Cited by in Crossref: 69] [Cited by in F6Publishing: 68] [Article Influence: 4.1] [Reference Citation Analysis]
87 Schwartz MD, Kilduff TS. The Neurobiology of Sleep and Wakefulness. Psychiatr Clin North Am 2015;38:615-44. [PMID: 26600100 DOI: 10.1016/j.psc.2015.07.002] [Cited by in Crossref: 83] [Cited by in F6Publishing: 70] [Article Influence: 11.9] [Reference Citation Analysis]
88 Umehara H, Mizuguchi H, Fukui H. Identification of a histaminergic circuit in the caudal hypothalamus: an evidence for functional heterogeneity of histaminergic neurons. Neurochem Int 2012;61:942-7. [PMID: 22677810 DOI: 10.1016/j.neuint.2012.05.022] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
89 Dugovic C, Shelton JE, Aluisio LE, Fraser IC, Jiang X, Sutton SW, Bonaventure P, Yun S, Li X, Lord B, Dvorak CA, Carruthers NI, Lovenberg TW. Blockade of orexin-1 receptors attenuates orexin-2 receptor antagonism-induced sleep promotion in the rat. J Pharmacol Exp Ther 2009;330:142-51. [PMID: 19363060 DOI: 10.1124/jpet.109.152009] [Cited by in Crossref: 150] [Cited by in F6Publishing: 154] [Article Influence: 11.5] [Reference Citation Analysis]
90 Moriwaki C, Chiba S, Wei H, Aosa T, Kitamura H, Ina K, Shibata H, Fujikura Y. Distribution of histaminergic neuronal cluster in the rat and mouse hypothalamus. Journal of Chemical Neuroanatomy 2015;68:1-13. [DOI: 10.1016/j.jchemneu.2015.07.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
91 Tsunematsu T, Tabuchi S, Tanaka KF, Boyden ES, Tominaga M, Yamanaka A. Long-lasting silencing of orexin/hypocretin neurons using archaerhodopsin induces slow-wave sleep in mice. Behav Brain Res 2013;255:64-74. [PMID: 23707248 DOI: 10.1016/j.bbr.2013.05.021] [Cited by in Crossref: 71] [Cited by in F6Publishing: 72] [Article Influence: 7.9] [Reference Citation Analysis]
92 Jia X, Yan J, Xia J, Xiong J, Wang T, Chen Y, Qi A, Yang N, Fan S, Ye J, Hu Z. Arousal effects of orexin A on acute alcohol intoxication-induced coma in rats. Neuropharmacology 2012;62:775-83. [PMID: 21924278 DOI: 10.1016/j.neuropharm.2011.08.047] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
93 Jones BE. Modulation of cortical activation and behavioral arousal by cholinergic and orexinergic systems. Ann N Y Acad Sci 2008;1129:26-34. [PMID: 18591466 DOI: 10.1196/annals.1417.026] [Cited by in Crossref: 108] [Cited by in F6Publishing: 103] [Article Influence: 7.7] [Reference Citation Analysis]
94 Ishizuka T, Murotani T, Yamatodani A. Action of Modafinil Through Histaminergic and Orexinergic Neurons. Sleep Hormones. Elsevier; 2012. pp. 259-78. [DOI: 10.1016/b978-0-12-394623-2.00014-7] [Cited by in Crossref: 23] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
95 Kukkonen JP. Physiology of the orexinergic/hypocretinergic system: a revisit in 2012. Am J Physiol Cell Physiol 2013;304:C2-32. [PMID: 23034387 DOI: 10.1152/ajpcell.00227.2012] [Cited by in Crossref: 93] [Cited by in F6Publishing: 91] [Article Influence: 9.3] [Reference Citation Analysis]
96 Mieda M, Tsujino N, Sakurai T. Differential roles of orexin receptors in the regulation of sleep/wakefulness. Front Endocrinol (Lausanne) 2013;4:57. [PMID: 23730297 DOI: 10.3389/fendo.2013.00057] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 3.1] [Reference Citation Analysis]
97 Hoang QV, Bajic D, Yanagisawa M, Nakajima S, Nakajima Y. Effects of orexin (hypocretin) on GIRK channels. J Neurophysiol 2003;90:693-702. [PMID: 12702704 DOI: 10.1152/jn.00001.2003] [Cited by in Crossref: 63] [Cited by in F6Publishing: 59] [Article Influence: 3.3] [Reference Citation Analysis]
98 Torrealba F, Riveros ME, Contreras M, Valdes JL. Histamine and motivation. Front Syst Neurosci 2012;6:51. [PMID: 22783171 DOI: 10.3389/fnsys.2012.00051] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 3.8] [Reference Citation Analysis]
99 Ahmadi-soleimani SM, Mianbandi V, Azizi H, Azhdari-zarmehri H, Ghaemi-jandabi M, Abbasi-mazar A, Mohajer Y, Darana SP. Coregulation of sleep-pain physiological interplay by orexin system: An unprecedented review. Behavioural Brain Research 2020;391:112650. [DOI: 10.1016/j.bbr.2020.112650] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
100 Arrang J. Histamine and Schizophrenia. Integrating the Neurobiology of Schizophrenia. Elsevier; 2007. pp. 247-87. [DOI: 10.1016/s0074-7742(06)78009-6] [Cited by in Crossref: 28] [Cited by in F6Publishing: 7] [Article Influence: 1.9] [Reference Citation Analysis]
101 Schmitt O, Usunoff KG, Lazarov NE, Itzev DE, Eipert P, Rolfs A, Wree A. Orexinergic innervation of the extended amygdala and basal ganglia in the rat. Brain Struct Funct 2012;217:233-56. [DOI: 10.1007/s00429-011-0343-8] [Cited by in Crossref: 53] [Cited by in F6Publishing: 51] [Article Influence: 4.8] [Reference Citation Analysis]
102 Wang D, Guo Q, Zhou Y, Xu Z, Hu SW, Kong XX, Yu YM, Yang JX, Zhang H, Ding HL, Cao JL. GABAergic Neurons in the Dorsal-Intermediate Lateral Septum Regulate Sleep-Wakefulness and Anesthesia in Mice. Anesthesiology 2021. [PMID: 34259824 DOI: 10.1097/ALN.0000000000003868] [Reference Citation Analysis]
103 de Biase S, Nilo A, Gigli GL, Valente M. Investigational therapies for the treatment of narcolepsy. Expert Opin Investig Drugs 2017;26:953-63. [PMID: 28726523 DOI: 10.1080/13543784.2017.1356819] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
104 Wang ZH, Ni XL, Li JN, Xiao ZY, Wang C, Zhang LN, Tong L, Dong HL. Changes in plasma orexin-A levels in sevoflurane-remifentanil anesthesia in young and elderly patients undergoing elective lumbar surgery. Anesth Analg. 2014;118:818-822. [PMID: 24651236 DOI: 10.1213/ane.0000000000000109] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 1.4] [Reference Citation Analysis]
105 Nishino S. Hypothalamus, hypocretins/orexin, and vigilance control. Sleep Disorders. Elsevier; 2011. pp. 765-82. [DOI: 10.1016/b978-0-444-52007-4.00006-0] [Cited by in Crossref: 19] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
106 Mieda M. The roles of orexins in sleep/wake regulation. Neuroscience Research 2017;118:56-65. [DOI: 10.1016/j.neures.2017.03.015] [Cited by in Crossref: 42] [Cited by in F6Publishing: 39] [Article Influence: 8.4] [Reference Citation Analysis]
107 Nishino S. The Canine Model of Narcolepsy. In: de Lecea L, Sutcliffe JG, editors. Hypocretins. Boston: Springer US; 2005. pp. 39-58. [DOI: 10.1007/0-387-25446-3_4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
108 Mieda M, Sakurai T. Orexin (hypocretin) receptor agonists and antagonists for treatment of sleep disorders. Rationale for development and current status. CNS Drugs 2013;27:83-90. [PMID: 23359095 DOI: 10.1007/s40263-012-0036-8] [Cited by in Crossref: 62] [Cited by in F6Publishing: 62] [Article Influence: 6.9] [Reference Citation Analysis]
109 Bisetti A, Cvetkovic V, Serafin M, Bayer L, Machard D, Jones B, Mühlethaler M. Excitatory action of hypocretin/orexin on neurons of the central medial amygdala. Neuroscience 2006;142:999-1004. [DOI: 10.1016/j.neuroscience.2006.07.018] [Cited by in Crossref: 73] [Cited by in F6Publishing: 68] [Article Influence: 4.6] [Reference Citation Analysis]
110 Coleman P, de Lecea L, Gotter A, Hagan J, Hoyer D, Kilduff T, Kukkonen JP, Porter R, Renger J, Siegel JM, Sutcliffe G, Upton N, Winrow CJ. Orexin receptors in GtoPdb v.2021.3. IUPHAR BPS Guide Pharm CITE 2021;2021. [PMID: 34927075 DOI: 10.2218/gtopdb/f51/2021.3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
111 Li SB, de Lecea L. The hypocretin (orexin) system: from a neural circuitry perspective. Neuropharmacology 2020;167:107993. [PMID: 32135427 DOI: 10.1016/j.neuropharm.2020.107993] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 14.5] [Reference Citation Analysis]
112 Perez-Leighton CE, Billington CJ, Kotz CM. Orexin modulation of adipose tissue. Biochim Biophys Acta 2014;1842:440-5. [PMID: 23791983 DOI: 10.1016/j.bbadis.2013.06.007] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
113 Willie JT, Chemelli RM, Sinton CM, Tokita S, Williams SC, Kisanuki YY, Marcus JN, Lee C, Elmquist JK, Kohlmeier KA, Leonard CS, Richardson JA, Hammer RE, Yanagisawa M. Distinct narcolepsy syndromes in Orexin receptor-2 and Orexin null mice: molecular genetic dissection of Non-REM and REM sleep regulatory processes. Neuron 2003;38:715-30. [PMID: 12797957 DOI: 10.1016/s0896-6273(03)00330-1] [Cited by in Crossref: 410] [Cited by in F6Publishing: 190] [Article Influence: 21.6] [Reference Citation Analysis]
114 Yamanaka A, Tsunematsu T. New approaches for the study of orexin function. J Neuroendocrinol 2010;22:818-24. [PMID: 20456607 DOI: 10.1111/j.1365-2826.2010.02015.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
115 Brown RE, Basheer R, McKenna JT, Strecker RE, McCarley RW. Control of sleep and wakefulness. Physiol Rev 2012;92:1087-187. [PMID: 22811426 DOI: 10.1152/physrev.00032.2011] [Cited by in Crossref: 700] [Cited by in F6Publishing: 590] [Article Influence: 70.0] [Reference Citation Analysis]
116 Alcaraz-iborra M, Carvajal F, Lerma-cabrera JM, Valor LM, Cubero I. Binge-like consumption of caloric and non-caloric palatable substances in ad libitum-fed C57BL/6J mice: Pharmacological and molecular evidence of orexin involvement. Behavioural Brain Research 2014;272:93-9. [DOI: 10.1016/j.bbr.2014.06.049] [Cited by in Crossref: 44] [Cited by in F6Publishing: 39] [Article Influence: 5.5] [Reference Citation Analysis]
117 Thannickal TC, Siegel JM, Nienhuis R, Moore RY. Pattern of hypocretin (orexin) soma and axon loss, and gliosis, in human narcolepsy. Brain Pathol. 2003;13:340-351. [PMID: 12946023 DOI: 10.1111/j.1750-3639.2003.tb00033.x] [Cited by in Crossref: 85] [Cited by in F6Publishing: 78] [Article Influence: 4.5] [Reference Citation Analysis]
118 Takahashi K, Lin JS, Sakai K. Neuronal activity of histaminergic tuberomammillary neurons during wake-sleep states in the mouse. J Neurosci 2006;26:10292-8. [PMID: 17021184 DOI: 10.1523/JNEUROSCI.2341-06.2006] [Cited by in Crossref: 202] [Cited by in F6Publishing: 101] [Article Influence: 12.6] [Reference Citation Analysis]
119 Shen YC, Sun X, Li L, Zhang HY, Huang ZL, Wang YQ. Roles of Neuropeptides in Sleep-Wake Regulation. Int J Mol Sci 2022;23:4599. [PMID: 35562990 DOI: 10.3390/ijms23094599] [Reference Citation Analysis]
120 Sundvik M, Kudo H, Toivonen P, Rozov S, Chen YC, Panula P. The histaminergic system regulates wakefulness and orexin/hypocretin neuron development via histamine receptor H1 in zebrafish. FASEB J 2011;25:4338-47. [PMID: 21885652 DOI: 10.1096/fj.11-188268] [Cited by in Crossref: 47] [Cited by in F6Publishing: 50] [Article Influence: 4.3] [Reference Citation Analysis]
121 John J, Wu M, Boehmer LN, Siegel JM. Cataplexy-Active Neurons in the Hypothalamus. Neuron 2004;42:619-34. [DOI: 10.1016/s0896-6273(04)00247-8] [Cited by in Crossref: 131] [Cited by in F6Publishing: 69] [Article Influence: 7.3] [Reference Citation Analysis]
122 Mamelak M. Narcolepsy and depression and the neurobiology of gammahydroxybutyrate. Prog Neurobiol 2009;89:193-219. [PMID: 19654034 DOI: 10.1016/j.pneurobio.2009.07.004] [Cited by in Crossref: 47] [Cited by in F6Publishing: 38] [Article Influence: 3.6] [Reference Citation Analysis]
123 Modirrousta M, Mainville L, Jones BE. Orexin and MCH neurons express c-Fos differently after sleep deprivation vs. recovery and bear different adrenergic receptors. Eur J Neurosci 2005;21:2807-16. [PMID: 15926928 DOI: 10.1111/j.1460-9568.2005.04104.x] [Cited by in Crossref: 138] [Cited by in F6Publishing: 139] [Article Influence: 8.1] [Reference Citation Analysis]
124 Zhao P, Shao Y, Zhang M, Fan K, Kong X, Wang R, Hou Y. Neuropeptide S promotes wakefulness through activation of the posterior hypothalamic histaminergic and orexinergic neurons. Neuroscience 2012;207:218-26. [DOI: 10.1016/j.neuroscience.2012.01.022] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 2.9] [Reference Citation Analysis]
125 Sakurai T, Mieda M, Tsujino N. The orexin system: roles in sleep/wake regulation: Orexin and sleep/wake state. Annals of the New York Academy of Sciences 2010;1200:149-61. [DOI: 10.1111/j.1749-6632.2010.05513.x] [Cited by in Crossref: 125] [Cited by in F6Publishing: 111] [Article Influence: 10.4] [Reference Citation Analysis]
126 Scammell TE. The neurobiology, diagnosis, and treatment of narcolepsy. Ann Neurol 2003;53:154-66. [DOI: 10.1002/ana.10444] [Cited by in Crossref: 155] [Cited by in F6Publishing: 130] [Article Influence: 8.2] [Reference Citation Analysis]
127 Takahashi K, Lin JS, Sakai K. Neuronal activity of orexin and non-orexin waking-active neurons during wake-sleep states in the mouse. Neuroscience 2008;153:860-70. [PMID: 18424001 DOI: 10.1016/j.neuroscience.2008.02.058] [Cited by in Crossref: 161] [Cited by in F6Publishing: 150] [Article Influence: 11.5] [Reference Citation Analysis]
128 Leonard CS, Kukkonen JP. Orexin/hypocretin receptor signalling: a functional perspective. Br J Pharmacol 2014;171:294-313. [PMID: 23848055 DOI: 10.1111/bph.12296] [Cited by in Crossref: 82] [Cited by in F6Publishing: 84] [Article Influence: 10.3] [Reference Citation Analysis]
129 Toth A, Balatoni B, Hajnik T, Detari L. EEG effect of orexin A in freely moving rats. Acta Physiologica Hungarica 2012;99:332-43. [DOI: 10.1556/aphysiol.99.2012.3.10] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
130 Sutcliffe JG, de Lecea L. The hypocretins: Setting the arousal threshold. Nat Rev Neurosci 2002;3:339-48. [DOI: 10.1038/nrn808] [Cited by in Crossref: 310] [Cited by in F6Publishing: 293] [Article Influence: 15.5] [Reference Citation Analysis]
131 Arrang J. Le récepteur H3 de l’histamine : une cible pour de nouveaux traitements des troubles de l’éveil et de la cognition. Annales Pharmaceutiques Françaises 2007;65:275-84. [DOI: 10.1016/s0003-4509(07)90047-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
132 Tsunematsu T, Kilduff TS, Boyden ES, Takahashi S, Tominaga M, Yamanaka A. Acute optogenetic silencing of orexin/hypocretin neurons induces slow-wave sleep in mice. J Neurosci 2011;31:10529-39. [PMID: 21775598 DOI: 10.1523/JNEUROSCI.0784-11.2011] [Cited by in Crossref: 152] [Cited by in F6Publishing: 92] [Article Influence: 13.8] [Reference Citation Analysis]